Cancer
Trial reveals benefits of ‘stepped’ palliative care for patients with advanced lung cancer
BOSTON – A new study led by investigators from Mass General Cancer Center, a founding member of the Mass General...
Almost 20% of breast cancer survivors may experience excess weight gain
BOSTON—Almost one out of five breast cancer survivors may experience weight gain of more than 10%, suggests a study presented...
Immunotherapy significantly increases the number of patients free from bowel cancer
An immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more patients with a certain genetic...
Socioeconomic status influences genetic risk for many complex diseases
Berlin, Germany: Differences in socioeconomic status (SES) are known to be linked to differences in the risk of developing disease....
ASCO: New ‘Armored’ CAR produces significant responses in patients whose cancers don’t respond to current CAR T cell therapies
CHICAGO – While CAR T cell therapy has revolutionized treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many patients...
Experimental therapy shows promise in pancreatic cancer clinical trial
WASHINGTON --- Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first...
Clinical trials show promise in treating central nervous system lymphoma, breast cancer, and glioblastoma
Boston – Dana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous...
Molecular profiling improves diagnosis and survival for children with high risk cancers
Berlin, Germany: Cancer is the leading cause of disease-related death in children in most developed countries, and at least a...
Moffitt Cancer Center and Virogen Biotechnology forge groundbreaking partnership to accelerate oncology and immunotherapy innovations
TAMPA, Fla., and PLEASANTON, Calif. — Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Virogen Biotechnology Inc.,...
Ivonescimab plus chemotherapy in non–small cell lung cancer with EGFR variant
About The Study: Ivonescimab plus chemotherapy significantly improved progression-free survival with tolerable safety profile in patients with non–small cell lung cancer...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!